Tumour–microenvironment mediates resistance to immuno and targeted therapies in acral melanoma. (July 2016) - Lee, R.; Girotti, M.R.; Khandelwal, G.; Baenke, F.; Viros, A.; Mandal, A.; Bridgeman, J.; Galvani, E.; Gremel, G.; Kalaitsidou, M.; Ashton, G.; Peset, I.; et al.